Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;36(6):e24491.
doi: 10.1002/jcla.24491. Epub 2022 May 9.

Evaluation of conventional and point-of-care real-time RT-PCR tests for the detection of SARS-CoV-2 through a pooled testing strategy

Affiliations

Evaluation of conventional and point-of-care real-time RT-PCR tests for the detection of SARS-CoV-2 through a pooled testing strategy

Ji-Rong Yang et al. J Clin Lab Anal. 2022 Jun.

Abstract

Background: The rapid identification and isolation of individuals infected with SARS-CoV-2 are fundamental countermeasures for the efficient control of the COVID-19 pandemic, which has affected millions of people around the world. Real-time RT-PCR is one of the most commonly applied reference methods for virus detection, and the use of pooled testing has been proposed as an effective way to increase the throughput of routine diagnostic tests. However, the clinical applicability of different types of real-time RT-PCR tests in a given group size remains inconclusive due to inconsistent regional disease prevalence and test demands.

Methods: In this study, the performance of one dual-target conventional and two point-of-care real-time RT-PCR tests in a 5-specimen pooled testing strategy for the detection of SARS-COV-2 was evaluated.

Results: We demonstrated the proof of concept that all of these real-time RT-PCR tests could feasibly detect SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens that contain viral RNA loads in the range of 3.48 × 105 to 3.42 × 102 copies/ml through pooled testing in a group size of 5 with overall positive percent agreement (pooling vs. individual testing) ranging from 100% to 93.75%. Furthermore, the two POC real-time RT-PCR tests exhibited comparable sensitivity to that of the dual-target conventional one when clinical specimens were tested individually.

Conclusion: Our findings support the feasibility of using real-time RT-PCR tests developed as a variety of platforms in routine laboratory detection of suspected COVID-19 cases through a pooled testing strategy that is beneficial to increasing the daily diagnostic capacity.

Keywords: SARS-CoV-2; point-of-care; pooled testing; real-time RT-PCR.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Standard curves for dual‐target conventional real‐time RT‐PCR. Serial twofold dilutions of commercially purchased inactivated SARS‐CoV‐2 particles with known RNA loads ranging from 3500 copies/ml to 109.375 copies/ml were used for RNA extraction followed by real‐time RT‐PCR analysis of (A) E and (B) N2 assays. Each dilution of the standard curve was analyzed by 18 replicates, and the respective mean value is illustrated by dotted and hollow circles, respectively, with standard deviation shown as error bars. The viral RNA loads (log2 copies/ml) and the cycles of threshold (Ct) are indicated on the X‐ and Y‐axes, respectively
FIGURE 2
FIGURE 2
Comparison of Ct values of SARS‐CoV‐2 detection through individual and pooled testing strategies. Data of (A) dual‐target conventional real‐time RT–PCR, (B) Xpert Xpress, and (C) cobas Liat are presented as a scatter plot with mean values ± SD of the same testing strategy. The asterisks (**) and (***) indicate a significant difference (p < 0.01 and p < 0.0001, respectively) by a one‐tailed unpaired t test. The testing strategy and the resultant Ct values are indicated on the X‐ and Y‐axes, respectively

Similar articles

Cited by

References

    1. WHO . Recommendations for national SARS‐CoV‐2 testing strategies and diagnostic capacities. 2021. Accessed October 14, 2021.https://apps.who.int/iris/bitstream/handle/10665/342002/WHO‐2019‐nCoV‐la...
    1. Sharfstein JM, Becker SJ, Mello MM. Diagnostic testing for the novel coronavirus. JAMA. 2020;323:1437‐1438. - PubMed
    1. Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS‐CoV‐2). Science. 2020;368:489‐493. - PMC - PubMed
    1. Chappell JG, Tsoleridis T, Clark G, et al. Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS‐CoV‐2 in the United Kingdom. J Gen Virol. 2021;102(6). doi:10.1099/jgv.0.001595 - DOI - PMC - PubMed
    1. Pakzad R, Malekifar P, Shateri Z, et al. Worldwide prevalence of microbial agents’ coinfection among COVID‐19 patients: a comprehensive updated systematic review and meta‐analysis. J Clin Lab Anal. 2022;36:e24151. - PMC - PubMed